Evidence map›Paper›PMID 40619585›Full record

ArticleInternational journal of dermatology2025

The Burden of Skin and Subcutaneous Diseases in North Africa and the Middle East (NAME) From 1990 to 2021.

Ghida El Banna, Natalie Braun, Natalie M Baker, Bryan L Peacker, Kevin Sheng-Kai Ma, Abdul Ghani Kibbi, Steven T Chen

Abstract read
In one paragraph

Article in International journal of dermatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ghida El BannaDepartment of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.ORCID https://orcid.org/0000-0002-6534-2648
Natalie BraunDepartment of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Natalie M BakerDepartment of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Bryan L PeackerDepartment of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Kevin Sheng-Kai MaDepartment of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
Abdul Ghani KibbiDepartment of Dermatology, American University of Beirut Medical Center, Beirut, Lebanon.
Steven T ChenDepartment of Dermatology, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.

Funding

Pathways to Mentorship and Research: Training the Next Generation Physician-ScientistsR25AI147393 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI VYAS, JATIN M · 2019 to 2024
$1.8M
NIAID NIH HHS R25 AI147393NIH HHS R25AI147393
6 · The paper itself

Abstract

backgroundSkin diseases contribute significantly to morbidity worldwide, yet their burden in North Africa and the Middle East (NAME) remains poorly understood. This study aims to assess the burden of skin diseases in NAME from 1990 to 2021.

methodsUsing data from the Global Burden of Disease (GBD) study, we analyzed disability-adjusted life-years (DALYs) and age-adjusted prevalence, incidence, and mortality rates of 23 skin conditions across 21 NAME countries from 1990 to 2021.

resultsIn 2021, skin and subcutaneous diseases ranked as the 22nd leading cause of morbidity and mortality in NAME, with a 0.06% increase in DALYs since 1990 (95% confidence interval [CI]: 0.05%-0.08%). The most prevalent skin conditions (age-adjusted per 100,000) were other skin and subcutaneous diseases (6788.41), fungal skin diseases (3311.44), acne vulgaris (3102.51), atopic dermatitis (1374.93), viral skin diseases (1257.88), scabies (1009.72), contact dermatitis (998.89), pruritus (980.93), urticaria (936.13), and cutaneous leishmaniasis (642.73). Qatar experienced the largest DALYs increase in skin disease (0.12%; 95% CI: 0.07%-0.18%). Notable geographic variations included increased DALYs for acne vulgaris, psoriasis, and viral skin diseases across all countries; a rise in cutaneous leishmaniasis in Afghanistan, Syria, and Morocco; and a decline in measles, varicella-herpes zoster, and leprosy (except in Iran).

conclusionSkin diseases impose a significant and evolving burden in NAME, with notable temporal and geographic variations. Further research is needed to better understand disease epidemiology and guide future interventions.

Indexed as

Skin DiseasesAdolescentAdultAfrica, NorthernChildCost of IllnessDisability-Adjusted Life YearsFemaleGlobal Burden of DiseaseHumansIncidenceMaleMiddle AgedMiddle EastPrevalenceYoung Adult

Identifiers

PMID40619585
PMCPMC12483311

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.